HIV Vaccine Regimen Demonstrates Modest Preventive Effect in Thailand Clinical Study
Posted on Monday, September 28th, 2009 at 12:00 pmIn an encouraging development, an investigational vaccine regimen has been shown to be well-tolerated and to prevent HIV infection in a clinical trial involving more than 16,000 adult participants in Thailand.
Following a final analysis of the trial data, the Surgeon General of the U.S. Army, the trial sponsor, announced today that the prime-boost investigational vaccine regimen was safe and 31 percent effective in preventing HIV infection.
“These new findings represent an important step forward in HIV vaccine research,” says Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH, which provided major funding and other support for the study.
“For the first time, an investigational HIV vaccine has demonstrated some ability to prevent HIV infection among vaccinated individuals. Additional research is needed to better understand how this vaccine regimen reduced the risk of HIV infection, but certainly this is an encouraging advance for the HIV vaccine field.”
For more information – Talk about clinical trials and vaccine research – Talk about HIV – More HIV Information
I have a disease and im a diabetic also. what do i have? little bumps down there that burn and itch
What disease do you have? Have you made an appointment to see your doctor so that you can figure out what your symptoms are?